文献速递临床生化临床免疫

血清维生素B12液相色谱串联质谱法可作为免疫分析法结果不一致时的仲裁方法

Total serum vitamin B12 (cobalamin) LC-MS/MS assay as an arbiter of clinically discordant immunoassay results.
PubMed 文献 · Clin Chem Lab Med · 2022-09-15

本研究开发了将不同形式维生素B12衍生物转化为CN-B12后经固相萃取和LC-MS/MS检测的方法,并与免疫分析法比较236份血清样本。LC-MS/MS在20-4,000 pmol/L范围内线性良好,与免疫分析法一致性高(加权kappa 0.885),但免疫分析法存在假性升高和假性正常结果,LC-MS/MS有助于鉴别假性正常VB12结果。

要点

  • LC-MS/MS可鉴别免疫分析法因IF-Ab等干扰导致的假性正常VB12结果。
  • 两法一致性良好(加权kappa 0.885),但免疫分析法仍有假性升高和假性正常。
  • LC-MS/MS线性范围20-4,000 pmol/L,批内CV 2.6-4.1%,总CV 9.3-9.8%。

核心结论

  • VB12 LC-MS/MS方法可作为临床免疫分析法结果不一致时的仲裁方法。

研究设计与样本

  • 研究方法:将不同形式VB12衍生物转化为CN-B12,经固相萃取后LC-MS/MS分析。
  • 样本量:236份血清样本同时用LC-MS/MS和免疫分析法测定并比较。

主要发现

  • LC-MS/MS对CN-B12线性范围为20-4,000 pmol/L。
  • OH-VB12、甲基-VB12和CoA-VB12回收率在89.3-109.5%之间。
  • VB12批内CV为2.6-4.1%,总CV为9.3-9.8%。
  • Passing-Bablok回归斜率1.085,截距-15.691;Bland-Altman平均差值-34.6 pmol/L,差值百分比0.3%。
  • 线性加权kappa值0.885,两法一致性良好;但免疫分析法有2例假性升高和1例假性正常。

关键数值与推荐

  • LC-MS/MS线性范围20-4,000 pmol/L(CN-B12)。
  • 回收率89.3-109.5%(OH-VB12、甲基-VB12、CoA-VB12)。
  • 批内CV 2.6-4.1%,总CV 9.3-9.8%。
  • Passing-Bablok回归斜率1.085,截距-15.691。
  • Bland-Altman平均差值-34.6 pmol/L,差值百分比0.3%;线性加权kappa 0.885。

临床怎么用

  • 当免疫分析法VB12结果与临床不一致(如怀疑IF-Ab干扰)时,可用LC-MS/MS复测仲裁。
  • LC-MS/MS有助于识别免疫分析法假性正常或假性升高的VB12结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Measurement of the serum levels of vitamin B12 (VB12) is key for evaluating VB12 deficiency-dependent anemia. Immunoassay, the major method for determining VB12, tends to give false-normal results because of the presence of anti-intrinsic factor (IF-Ab) or other factors such as heterophilic antibodies et al. This study aimed to develop a liquid chromatography tandem mass spectrometry (LC-MS/MS) method that is helpful for distinguish false normal VB12 results measured by the immunoassay. METHODS: Different forms of VB12 were derivatized into CN-B12, which was collected through solid-phase extraction and analyzed via LC-MS/MS. 236 serum samples were measured both by LC-MS/MS and immunoassay, results were compared, and the IF-Ab effect was evaluated. RESULTS: The LC-MS/MS assay afforded a linear slope from 20 to 4,000 pmol/L for CN-B12. OH-VB12, methyl-VB12, and CoA-VB12 showed recovery within 89.3-109.5%. The intra-assay CV of VB12 was 2.6-4.1%, whereas the total CV was 9.3-9.8%. Passing-Bablok regression between LC-MS/MS and immunoassay results showed that the slope was 1.085 and the intercept was -15.691. The Bland-Altman plot showed that the mean difference and difference% were -34.6 pmol/L and 0.3%, respectively. Inter-rater agreement analysis showed that the linear weighted kappa value was 0.885, implying good agreement between the two methods. However, two samples were falsely elevated and one sample was falsely normal in the immunoassay compared with LC-MS/MS. The LC-MS/MS method helped in the distinction of false-normal VB12 results shown by the immunoassay. CONCLUSIONS: The VB12 LC-MS/MS method can be used as an arbiter of clinically discordant immunoassay results.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Zhang R, Ma X, Zou Y, et al. Total serum vitamin B12 (cobalamin) LC-MS/MS assay as an arbiter of clinically discordant immunoassay results. Clin Chem Lab Med. 2022. PMID: 36103653. doi:10.1515/cclm-2022-0523

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。